Clinical Trial Update: Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of Pegylated-P-Interferon-alpha-2b (P1101) in treatment-naive Hepatitis C genotype 1 patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated-P-Interferon-alpha-2b (P1101) (Pegylated-P-Interferon-alpha-2b)

Snippet

Sponsor: PharmaEssentia | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED